The recent failure of the PROMESA clinical trial for multiple system atrophy raises the question—are polyphenols a viable therapeutic option against proteinopathies?

Skip to main content

Open Access Publications from the University of California

The recent failure of the PROMESA clinical trial for multiple system atrophy raises the question—are polyphenols a viable therapeutic option against proteinopathies?

2020

Bitan, Gal

Published Web Location

https://doi.org/10.21037/atm.2020.01.117